[Progress in Chimeric Antigen Receptor-Modified Natural Killer Cells for Multiple Myeloma].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 45(2): 290-297, 2023 Apr.
Article
in Zh
| MEDLINE
| ID: mdl-37157078
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
/
Multiple Myeloma
Type of study:
Prognostic_studies
Limits:
Animals
Language:
Zh
Journal:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
China